Abstract
Introduction In 1880, British ophthalmologist Henry Eales described Eales' disease for the first time(1). Recurrent vitreous hemorrhaging is a hallmark of Eales' disease(2). The systemic anti- tuberculosis and the steroids usually control the disease and subsequently resolve the vitreous hemorrhage(3), but when the vitreous hemorrhage persists, anti-VEGF is an option(4).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
